Algernon Pharmaceuticals Inc. C.AGN

AGN gains approval to conduct DMT trials in Netherlands

[biggonads]

While Algernon eyes one of the most significant catalysts possible for any biotech stock with its orphan designation with the FDA pending for its use of Ifenprodil, they are also advancing their other formulation with approval to conduct their DMT study in the Netherlands with a treatment aimed at helping those that have suffered neurologically from strokes. https://mugglehead.com/algernon-receives-approval-to-conduct-dmt-study-in-the-netherlands/